Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#111 / 183 Total
LCTX - Lineage Cell Therapeutics Inc - Stock Price Chart
TickerLCTX [AMEX, RUT]
CompanyLineage Cell Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap197.96MEPS (ttm)-0.12
P/E-EPS this Y5.56%
Forward P/E-EPS next Y-9.41%
PEG-EPS past 5Y19.25%
P/S22.12EPS next 5Y-
P/B2.90EPS Q/Q25.94%
Dividend-Sales Q/Q9.03%
Insider Own0.55%Inst Own48.22%
Insider Trans-Inst Trans0.01%
Short Float5.64%EarningsMar 07/a
Analyst Recom1.50Target Price5.20
Avg Volume947.66K52W Range0.84 - 1.61
Lineage Cell Therapeutics, Inc. operates as a clinical-stage biotechnology company developing new cellular therapies for degenerative retinal diseases, neurological conditions associated with demyelination, and aiding the body in detecting and combating cancer. The company's programs are based on two core proprietary technology platforms: cell replacement and cell and drug delivery. Its cell replacement platform creates new cells and tissues with its pluripotent and progenitor cell technologies. The company's cell and drug delivery programs are based upon its proprietary HyStem cell and drug delivery matrix technology. It engages in the research and development of regenerative medicine or therapeutic products for advancement in the field of oncology, orthopedics, retinal and neurological diseases and disorders, blood and vascular system diseases and disorders, blood plasma volume expansion, diagnostic products for the early detection of cancer and hydrogel products that may be used in surgery and products for human embryonic stem cell research. The company was founded by Judith Segall, Hal Sternberg, Paul E. Segall and Harold D. Waitz on November 30, 1990 and is headquartered in Carlsbad, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
BAILEY DON MDirectorFeb 08 '24Buy1.0496,155100,001158,801Feb 08 07:00 PM
BROADWOOD PARTNERS, L.P.DirectorFeb 06 '24Buy1.046,730,7707,000,00141,666,255Feb 08 06:58 PM
Jayasuriya AnulaDirectorDec 29 '23Buy1.0910,00010,90010,000Jan 02 07:08 PM
SCRM - Screaming Eagle Acquisition Corp - Stock Price Chart
TickerSCRM [NASD]
CompanyScreaming Eagle Acquisition Corp
CountryUSA
IndustryShell Companies
Market Cap355.71MEPS (ttm)0.18
P/E55.56EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B1.24EPS Q/Q-294.87%
Dividend-Sales Q/Q-
Insider Own53.32%Inst Own-
Insider Trans-8.37%Inst Trans36.89%
Short Float0.11%Earnings-
Analyst Recom-Target Price-
Avg Volume731.81K52W Range10.06 - 11.07
Screaming Eagle Acquisition Corp. is a blank check company. It was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses. The company was founded on November 3, 2021 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Alberta Investment Management Former 10% OwnerApr 19 '24Sale10.781,250,00013,475,0001,325,000Apr 23 04:23 PM
Flow State Investments, L.P.10% OwnerApr 12 '24Sale10.76500,0005,380,0001,591,821Apr 16 05:24 PM
SYNX - Silynxcom Ltd - Stock Price Chart
TickerSYNX [AMEX]
CompanySilynxcom Ltd
CountryUSA
IndustryCommunication Equipment
Market Cap-EPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-
Dividend-Sales Q/Q-
Insider Own-Inst Own-
Insider Trans-Inst Trans-
Short Float-Earnings-
Analyst Recom1.00Target Price8.00
Avg Volume11.94K52W Range2.82 - 4.10
OCEA - Ocean Biomedical Inc. - Stock Price Chart
TickerOCEA [NASD, RUT]
CompanyOcean Biomedical Inc.
CountryUSA
IndustryBiotechnology
Market Cap48.51MEPS (ttm)-3.83
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-587.66%
Dividend-Sales Q/Q-
Insider Own74.86%Inst Own13.49%
Insider Trans0.00%Inst Trans2.64%
Short Float7.39%Earnings-
Analyst Recom1.00Target Price18.50
Avg Volume6.95M52W Range0.52 - 12.08
Apr-24-24 04:51PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Annual Report on Form 10-K (GlobeNewswire)
Mar-28-24 01:15PM 13 Hot Stocks to Invest in According to Wall Street Analysts (Insider Monkey) -6.77%
08:01AM Ocean Biomedical (NASDAQ: OCEA) Congratulates JV Partner, Virion Therapeutics, on Promising First-Ever Human Phase 1B Clinical Safety Data for Their Lead Checkpoint Modifier-Containing Immunotherapy for HBV Functional Cure, at Global APASL (GlobeNewswire)
Mar-24-24 03:52PM 5 Best Biotech Penny Stocks to Invest In (Insider Monkey)
Mar-05-24 08:30AM Increasing Incidence of Pancreatic Cancer Leading to a $6.85 Billion Dollar Market Size for New Treatments (GlobeNewswire) +28.92%
Feb-29-24 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Joint Venture Partner, Virion Therapeutics to Present Their First Clinical Study Data as an Accepted Late Breaker Presentation at 2024 APASL Global Liver Meeting (GlobeNewswire) +14.29%
Dec-05-23 09:45AM EXCLUSIVE: Ocean Biomedical Announces Publication of Breast Cancer Research On New Tumor Suppression Pathway for Proprietary Antibody (Benzinga)
08:15AM Ocean Biomedical, Inc. Announces Publication of Groundbreaking Breast Cancer Research Uncovering a New Tumor Suppression Pathway for Its Proprietary Anti-Chi3L1 Antibody (GlobeNewswire)
Nov-29-23 05:41PM Ocean Biomedical, Inc. Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q (GlobeNewswire) -8.95%
Nov-14-23 08:01AM Ocean Biomedical (NASDAQ: OCEA) Announces Positive Preclinical Oncology Data for VRON-0300, Presented at SITC 2023 Annual Meeting, and Clinical Updates by 50/50 Joint Venture Partner Virion Therapeutics (GlobeNewswire) -15.36%
Ocean Biomedical, Inc. is a biopharmaceutical company. It engages in the business of discovering and developing therapeutic products in oncology, fibrosis, infectious diseases and inflammation. The company was founded by Chirinjeev Kathuria in June 2021 and is headquartered in Providence, RI.
VTGN - VistaGen Therapeutics Inc - Stock Price Chart
TickerVTGN [NASD]
CompanyVistaGen Therapeutics Inc
CountryUSA
IndustryBiotechnology
Market Cap119.20MEPS (ttm)-3.51
P/E-EPS this Y81.23%
Forward P/E-EPS next Y-22.54%
PEG-EPS past 5Y24.01%
P/S114.62EPS next 5Y-
P/B0.97EPS Q/Q84.74%
Dividend-Sales Q/Q129.06%
Insider Own10.12%Inst Own55.14%
Insider Trans0.00%Inst Trans-91.35%
Short Float5.32%EarningsFeb 13/a
Analyst Recom1.00Target Price13.00
Avg Volume264.40K52W Range1.62 - 24.71
VistaGen Therapeutics, Inc. is a late clinical-stage biopharmaceutical company, which engages in developing and commercializing medication and treatment for anxiety, depression, and other central nervous system disorders. Its product portfolio includes Fasedienol (PH94B) nasal spray for social anxiety disorder, Itruvone (PH10) nasal spray for depression disorders, AV-101 oral NMDR glycine site antagonist for depression and neurological disorders, PH15 acute treatment for improvement of cognition, PH80 acute management of vasomotor symptoms due to menopause, and PH284 acute management of Wasting syndrome (Cachexia). The company was founded by H. Ralph Snodgrass and Gordon Keller on May 26, 1998 and is headquartered in South San Francisco, CA.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
COMMODORE CAPITAL LP10% OwnerAug 07 '23Buy23.15775,75617,961,0791,575,000Aug 09 04:10 PM
INVO - INVO Bioscience Inc - Stock Price Chart
TickerINVO [NASD]
CompanyINVO Bioscience Inc
CountryUSA
IndustryMedical Devices
Market Cap2.55MEPS (ttm)-8.66
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y17.42%
P/S0.84EPS next 5Y-
P/B-EPS Q/Q82.40%
Dividend-Sales Q/Q396.78%
Insider Own0.96%Inst Own4.12%
Insider Trans0.00%Inst Trans-25.44%
Short Float0.65%EarningsApr 16/b
Analyst Recom3.00Target Price2.00
Avg Volume3.90M52W Range0.50 - 10.50
INVO BioScience, Inc. is a fertility company. It focuses on the creation of treatment options for patients diagnosed with infertility. It offers a patented medical device that is used for infertility treatment under the name INVOcell. The company was founded by Kathleen Karloff and Claude Ranoux on January 5, 2007 and is headquartered in Sarasota, FL.
KFFB - Kentucky First Federal Bancorp - Stock Price Chart
TickerKFFB [NASD]
CompanyKentucky First Federal Bancorp
CountryUSA
IndustryBanks - Regional
Market Cap29.37MEPS (ttm)-0.04
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-6.22%
P/S2.02EPS next 5Y-
P/B0.60EPS Q/Q-197.17%
Dividend5.51%Sales Q/Q24.35%
Insider Own0.32%Inst Own3.18%
Insider Trans0.00%Inst Trans-3.23%
Short Float0.06%Earnings-
Analyst Recom-Target Price-
Avg Volume4.41K52W Range3.53 - 6.84
Kentucky First Federal Bancorp is a bank holding company, which engages in the provision of banking products and services through its subsidiaries. The company was founded on March 2, 2005, and is headquartered in Hazard, KY.
WGS - GeneDx Holdings Corp - Stock Price Chart
TickerWGS [NASD]
CompanyGeneDx Holdings Corp
CountryUSA
IndustryHealth Information Services
Market Cap509.73MEPS (ttm)-5.25
P/E-EPS this Y65.21%
Forward P/E-EPS next Y62.29%
PEG-EPS past 5Y-
P/S2.30EPS next 5Y-
P/B2.46EPS Q/Q74.45%
Dividend-Sales Q/Q44.70%
Insider Own37.76%Inst Own42.38%
Insider Trans-7.20%Inst Trans-11.90%
Short Float6.57%EarningsApr 29/a
Analyst Recom2.00Target Price11.38
Avg Volume356.39K52W Range1.16 - 21.49
GeneDx Holdings Corp. is a patient centered health intelligence company. It engages in transforming healthcare by applying AI and machine learning to multidimensional, longitudinal clinical and genomic data to build dynamic models of human health and defining optimal, individualized health trajectories. The firm, through its Centrellis health intelligence platform, generates a more complete understanding of disease and wellness and provides science-driven solutions to the most pressing medical needs. The company was founded by Eric Schadt in October 2015 and is headquartered in Stamford, CT.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Feeley KevinCHIEF FINANCIAL OFFICERApr 29 '24Option Exercise0.003,013031,940Apr 30 04:27 PM
Stueland KatherineChief Executive OfficerApr 29 '24Option Exercise0.0015,496082,194Apr 30 04:30 PM
Stueland KatherineChief Executive OfficerApr 29 '24Sale11.046,32569,80875,869Apr 30 04:30 PM
Feeley KevinCHIEF FINANCIAL OFFICERApr 29 '24Sale11.041,10412,18530,836Apr 30 04:27 PM
Stueland KatherineCHIEF EXECUTIVE OFFICERMar 18 '24Sale10.598,55990,66166,698Mar 19 04:15 PM
BYU - Baiyu Holdings Inc - Stock Price Chart
TickerBYU [NASD]
CompanyBaiyu Holdings Inc
CountryChina
IndustryOther Industrial Metals & Mining
Market Cap21.23MEPS (ttm)0.07
P/E14.42EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y42.87%
P/S0.16EPS next 5Y-
P/B0.05EPS Q/Q4857.89%
Dividend-Sales Q/Q84.89%
Insider Own58.18%Inst Own0.56%
Insider Trans0.00%Inst Trans-90.61%
Short Float0.07%Earnings-
Analyst Recom1.00Target Price12.00
Avg Volume76.91K52W Range1.11 - 57.00
BAIYU Holdings, Inc. engages in the sale of metal products and provision of supply chain solutions. It operates through the Commodities Trading Business and Supply Chain Services segments. The company was founded on December 19, 2011, and is headquartered in Shenzhen, China.
BHAT - Blue Hat Interactive Entertainment Technology - Stock Price Chart
TickerBHAT [NASD]
CompanyBlue Hat Interactive Entertainment Technology
CountryChina
IndustryElectronic Gaming & Multimedia
Market Cap11.08MEPS (ttm)-
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S-EPS next 5Y-
P/B-EPS Q/Q-141.05%
Dividend-Sales Q/Q-92.09%
Insider Own29.69%Inst Own2.86%
Insider Trans0.00%Inst Trans25.60%
Short Float0.41%Earnings-
Analyst Recom-Target Price-
Avg Volume106.70K52W Range0.70 - 3.00
Blue Hat Interactive Entertainment Technology is a holding company, which engages in the production, development, and operation of augmented reality (AR) interactive entertainment games and toys. The firm also provides communication and Internet Data Center services. It offers the following AR interactive product lines: AR Racer, AR Need a Spanking, AR 3D Magic Box, and AR Picture Book. AR Racer is a car-racing mobile game with a small physical toy car that is placed onto the user's mobile device screen. AR Need a Spanking is a combat game with a ladybug shaped electronic toy. AR 3D Magic Box uses AR recognition technology to allow children to draw shapes or objects onto a physical card while the mobile game captures the drawings and animates them in a set background. AR Picture Book provides an educational and interactive experience that allows stories to come to life. The company was founded in 2010 and is headquartered in Xiamen, China.
1789101112131415161719